Cervix Cancer
115
24
35
50
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.8%
9 terminated out of 115 trials
84.7%
-1.8% vs benchmark
6%
7 trials in Phase 3/4
18%
9 of 50 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 50 completed trials
Clinical Trials (115)
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
Survival Monitoring in Russian Cancer Registries
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
Cervix Hypoxia FAZA
AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer
Predictive Clinical and Biological Parameters in Gynecological Cancer
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
GYNecologic Cancer-Related COGnitive Impairment
Study of a Predictor for Cervix Cancer
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer